Talkiatry pushes therapy nationwide to tighten virtual mental health care

Talkiatry is extending therapy services across all 50 states, a move that deepens its effort to build a single behavioral health platform spanning medication management, psychotherapy and higher-acuity care. The expansion gives the company a broader clinical footprint at a moment when access to mental healthcare remains fractured by network barriers, state licensing rules and long wait times.

The company built its business around telepsychiatry, then layered therapy onto that foundation. It now directly employs more than 400 therapists, and 85% of them are licensed in multiple states. More than 800 employed psychiatrists sit at the center of the model, which Talkiatry says makes it the nation’s largest private employer of psychiatrists and the preferred in-network psychiatry partner for more than 70 U.S. health systems.

The clinical logic is straightforward. When a patient’s psychiatrist and therapist work inside separate networks, communication often breaks down. Notes do not move cleanly, treatment plans drift, and patients are left to manage two disconnected care relationships while symptoms continue to evolve. By placing both disciplines in the same system, Talkiatry is betting that tighter coordination will improve continuity, reduce friction and keep patients engaged longer.

One platform for therapy, psychiatry and stepped care

Georgia Gaveras, Talkiatry’s co-founder and chief medical officer, framed the expansion as a way to give clinicians a more coordinated behavioral health experience. She has practiced psychiatry for more than 18 years and is triple board-certified in child and adolescent psychiatry, adult psychiatry and addiction medicine.

Her argument centers on workflow as much as access. Psychiatrists often need therapists they can trust, but finding in-network referrals is difficult, and coordination across outside providers can be slow or incomplete. In Talkiatry’s model, psychiatrists and therapists can share notes and communicate directly within the same ecosystem, which makes it easier to align psychotherapy with medication management.

A therapy visit can do more than add another appointment to the schedule. In a behavioral health system organized around severity, therapy can serve as the steady middle layer between brief medication check-ins and more intensive interventions. That matters for conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, bipolar disorder, insomnia and post-traumatic stress disorder, all of which sit within Talkiatry’s treatment scope.

The company is also moving beyond individual therapy. It has expanded into group therapy, plans to pilot an Intensive Outpatient Program, and is exploring specialty treatment for substance use. Those steps suggest a broader ambition: not just to place patients with a psychiatrist faster, but to build a stepped-care platform that can absorb more of the behavioral health continuum before a patient lands in an emergency department or falls out of care altogether.

Access barriers remain severe across the U.S.

National treatment gaps give the expansion context. Only around half of the nearly 60 million U.S. adults with a mental illness receive treatment in a given year, and the average wait time to obtain behavioral health services is 48 days. For patients who do make it into care, the system still forces many of them into separate networks for therapy and psychiatry, with little communication between the two.

Workforce shortages make that fragmentation harder to ignore. About 137 million Americans, or 40% of the U.S. population, live in federally designated Mental Health Professional Shortage Areas. HRSA projects that the supply of psychiatrists will shrink by roughly 20% by 2030.

Those numbers help explain why telehealth took hold so quickly in mental healthcare, but they also expose a central weakness in the post-pandemic model. Virtual access widened the door, yet licensure rules and payer variation created a patchwork system in which a patient can suddenly lose access after moving, traveling or crossing a state line. Gaveras described that instability as a moving target, and the criticism lands because behavioral health depends heavily on continuity. A patient who is stabilizing after a depressive episode or substance-related crisis does not benefit from an abrupt administrative interruption.

Outcomes data are being used to support the model

Talkiatry points to several internal and published data points to support its coordinated-care approach. Patients who see both a Talkiatry therapist and psychiatrist stay connected to care twice as long as patients receiving psychiatric care alone, according to company executives. Nearly 85% of therapists build a positive therapeutic relationship with their patients within the first month of care, based on the company’s clinical quality measure.

The company also cites peer-reviewed evidence from its fully virtual psychiatry model. In a study of Talkiatry patients, people with moderate-to-severe symptoms had average reductions of 46% in anxiety symptoms and 45% in depressive symptoms over roughly three months of treatment. A separate peer-reviewed study found that Talkiatry’s early dropout rate was up to 60% lower than industry benchmarks.

Those results are consistent with a clinical intuition that is easy to overlook in a digital-first market: patients do better when care feels continuous. Lower dropout means less drift, fewer lost-to-follow-up cases and more opportunities to adjust treatment before symptoms worsen. In behavioral health, that can be as important as the initial prescription.

AI tools and payer reach are shaping the expansion strategy

Talkiatry’s care model is also tied to proprietary AI-powered technology designed to manage care delivery, streamline clinical operations and engage members. Gaveras said the company uses AI to improve the experience for both patients and doctors, including AI scribes for note-taking. In a high-volume behavioral health practice, administrative load can erode face-to-face time and worsen clinician fatigue. Automation may not replace clinical judgment, but it can remove some of the clerical burden that slows care.

The scale of the company’s payer relationships gives the model commercial weight. Talkiatry spans more than 100 insurers, covers over 170 million lives and has delivered more than 4 million patient visits. In February, the company raised $210 million in Series D financing, bringing total funding to $400 million. It also entered a partnership with AMGA in April to expand access to in-network psychiatric care for medical groups and their patients.

Health systems and employers are likely watching this expansion closely because they need behavioral health partners that can absorb demand without weakening continuity. Gaveras argued that health systems are not looking for a company to replace local resources; they need a partner that can supplement them and provide timely access. In practical terms, that means fewer dead-end referrals and a greater chance that a patient will land in a system capable of managing both therapy and medication.

Policy pressure is building around telepsychiatry

The regulatory backdrop remains unsettled. The Mental Health TALK SAFE Act of 2025 seeks to expand access to high-quality psychiatric care through telemedicine while strengthening patient safety and accountability. In a September commentary in the American Journal of Managed Care, Jesse Ehrenfeld, M.D., urged Congress to move the legislation forward and argued that permanent telehealth prescribing and licensing rules would expand telepsychiatry access.

Talkiatry’s nationwide therapy rollout fits squarely into that policy debate. Virtual care has already changed how patients enter the mental health system. The harder question now is whether platforms can convert access into durable, coordinated treatment without recreating the same fragmentation that pushed people away from care in the first place. The company’s next test will be whether group therapy, outpatient programming and specialty substance use services can extend the model without diluting the coordination it is trying to protect.


Reporting by Dr. A. Manasa, MBBS for Medicine World Foundation, with additional data provided by Fierce Healthcare.